PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Naftidrofuryl oxalate - Peripheral arterial disease
PAD Profile : Naftidrofuryl oxalate - Peripheral arterial disease
Keywords :
Intermittent claudication, peripheral vascular disease, atherosclerosis,
Brand Names Include :
Praxilene
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
NICE Technology Appraisal
NICE TA223 - Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for periphera
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Naftidrofuryl has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Praxilene, was considered BLACK at the PCN in May 2017.
Associated BNF Codes
02. Cardiovascular System
02.06.04. Peripheral vasodilators and related drugs